Paper36901807
Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.
Maier S and 6 others. Int J Mol Sci, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. Papers, record 36901807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901807
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple Sclerosis | Major topic |
| Multiple Sclerosis, Chronic Progressive | Major topic |
| Multiple Sclerosis, Relapsing-Remitting | Major topic |
| Humans | |
| Retrospective Studies | |
| Biomarkers | |
| Disease Progression |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 510/17.01.2022 | University of Medicine and Pharmacy, Science and Technology George Emil Palade Targu Mures | PubMed |
Source PubMed
References180
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29974667 | Correlation between cortical lesions and cognitive impairment in multiple sclerosis. | Brain Behav | 2018 | https://conductscience.org/library/papers/29974667 | PubMed |
| 2 | 31396148 | Prospective Assessment of No Evidence of Disease Activity-4 Status in Early Disease Stages of Multiple Sclerosis in Routine Clinical Practice. | Front Neurol | 2019 | https://conductscience.org/library/papers/31396148 | PubMed |
| 3 | 30467212 | Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine. | AJNR Am J Neuroradiol | 2018 | https://conductscience.org/library/papers/30467212 | PubMed |
| 4 | 22666330 | Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. | PLoS One | 2012 | https://conductscience.org/library/papers/22666330 | PubMed |
| 5 | 31608004 | Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis. | Front Neurol | 2019 | https://conductscience.org/library/papers/31608004 | PubMed |
| 6 | 34906813 | Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis. | Mult Scler Relat Disord | 2022 | https://conductscience.org/library/papers/34906813 | PubMed |
| 7 | 23077021 | Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. | Neurology | 2012 | https://conductscience.org/library/papers/23077021 | PubMed |
| 8 | 31363847 | A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. | J Neurol | 2021 | https://conductscience.org/library/papers/31363847 | PubMed |
| 9 | 25732842 | Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis. | Mult Scler | 2015 | https://conductscience.org/library/papers/25732842 | PubMed |
| 10 | 34445097 | Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445097 | PubMed |
| 11 | 27803641 | The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences. | Int J MS Care | 2016 | https://conductscience.org/library/papers/27803641 | PubMed |
| 12 | 35534236 | Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis. | Neurol Neuroimmunol Neuroinflamm | 2022 | https://conductscience.org/library/papers/35534236 | PubMed |
| 13 | 33146954 | Blood neurofilament light: a critical review of its application to neurologic disease. | Ann Clin Transl Neurol | 2020 | https://conductscience.org/library/papers/33146954 | PubMed |
| 14 | 23007702 | Progressive multiple sclerosis: pathology and pathogenesis. | Nat Rev Neurol | 2012 | https://conductscience.org/library/papers/23007702 | PubMed |
| 15 | 30175165 | Identification of MS-specific serum miRNAs in an international multicenter study. | Neurol Neuroimmunol Neuroinflamm | 2018 | https://conductscience.org/library/papers/30175165 | PubMed |
| 16 | 33194221 | Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis. | Mult Scler J Exp Transl Clin | 2020 | https://conductscience.org/library/papers/33194221 | PubMed |
| 17 | 30614590 | Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis. | Eur J Neurol | 2019 | https://conductscience.org/library/papers/30614590 | PubMed |
| 18 | 26663180 | microRNAs and Neurodegenerative Diseases. | Adv Exp Med Biol | 2015 | https://conductscience.org/library/papers/26663180 | PubMed |
| 19 | 32587320 | Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis. | Sci Rep | 2020 | https://conductscience.org/library/papers/32587320 | PubMed |
| 20 | 31549947 | Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis. | Radiology | 2019 | https://conductscience.org/library/papers/31549947 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737436 | Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737436 | PubMed |
| 42511484 | MicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511484 | PubMed |
| 42445199 | Multiple sclerosis as an asynchronous neuroinflammatory system. | Front Immunol | 2026 | https://conductscience.org/library/papers/42445199 | PubMed |
| 42022617 | Long-Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real-World Longitudinal Study. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42022617 | PubMed |
| 41652249 | Patient-reported gradual worsening reveals progression beyond MS subtypes. | J Neurol | 2026 | https://conductscience.org/library/papers/41652249 | PubMed |
| 40806624 | The Redox Revolution in Brain Medicine: Targeting Oxidative Stress with AI, Multi-Omics and Mitochondrial Therapies for the Precision Eradication of Neurodegeneration. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806624 | PubMed |
| 40332781 | Exosomal microRNAs as Early Transition Biomarkers from Recurrent-Remissive to Secondary Progressive Multiple Sclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332781 | PubMed |
| 38542441 | The Impact of Sample Storage on Blood Methylation: Towards Assessing Myelin Gene Methylation as a Biomarker for Progressive Multiple Sclerosis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542441 | PubMed |
| 38542037 | Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression. | J Clin Med | 2024 | https://conductscience.org/library/papers/38542037 | PubMed |
| 38004272 | Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis. | Life (Basel) | 2023 | https://conductscience.org/library/papers/38004272 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901807
GET https://conductscience.org/api/papers/v1/36901807/references?page=2